Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Costa Clemens SA., Weckx L., Clemens R., Almeida Mendes AV., Ramos Souza A., Silveira MBV., da Guarda SNF., de Nobrega MM., de Moraes Pinto MI., Gonzalez IGS., Salvador N., Franco MM., de Avila Mendonça RN., Queiroz Oliveira IS., de Freitas Souza BS., Fraga M., Aley P., Bibi S., Cantrell L., Dejnirattisai W., Liu X., Mongkolsapaya J., Supasa P., Screaton GR., Lambe T., Voysey M., Pollard AJ., Bittaye M., Woods D., Davies S., Smith H., Ulaszewska M., Sanders H., Mabette R., Vernon S., Valliji Z., Mead G., Tejpal C., Park J., Beveridge A., Eldawi A., Felle S., Fraga M., Muniz Martins T., Martins Medrado CL., de Arruda Cordeiro Matos LJ.

DOI

10.1016/s0140-6736(22)00094-0

Type

Journal article

Publisher

Elsevier BV

Publication Date

2022-02-01T00:00:00+00:00

Volume

399

Pages

521 - 529

Total pages

8

Permalink More information Close